121 related articles for article (PubMed ID: 3997018)
1. [Treatment of depressive conditions with viloxazine by the general practitioner].
Haehn KD
Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
[No Abstract] [Full Text] [Related]
2. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
[No Abstract] [Full Text] [Related]
3. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
[No Abstract] [Full Text] [Related]
4. [The antidepressant viloxazin. A multicenter study under practice conditions].
Rüther E
Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
[TBL] [Abstract][Full Text] [Related]
5. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
[TBL] [Abstract][Full Text] [Related]
6. [A profile of the clinical effectiveness of second generation antidepressive agents].
Kabes J; Dostal T; Balon R; Papezová H
Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
[No Abstract] [Full Text] [Related]
7. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
[TBL] [Abstract][Full Text] [Related]
8. Do have antidepressants of the second generation anxiolytic properties?
Kabes J; Dostal T; Balon R
Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
[No Abstract] [Full Text] [Related]
9. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
Sebjanic V; Grombein S
Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
[TBL] [Abstract][Full Text] [Related]
10. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
Amin MM; Ban TA; Lehmann HE; Khan P
Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
[No Abstract] [Full Text] [Related]
11. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
Faravelli C; Tonini R; Zaccara G; Marchetti G
Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
[No Abstract] [Full Text] [Related]
12. [Clinical experimentation with viloxazine in depressive states].
Fontan M; Goudemand M; Pellerin-Millecamps E
Lille Med; 1979 Dec; 24(10):821-4. PubMed ID: 529970
[No Abstract] [Full Text] [Related]
13. The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter study.
Kabes J; Náhunek K; Molcan J; Hynek K; Dostal T; Svestka J; Faltus F; Caplová T
Act Nerv Super (Praha); 1978 Dec; 20(4):251-2. PubMed ID: 735719
[No Abstract] [Full Text] [Related]
14. [Comparative results of the treatment of anxiety in the depressive syndrome with Tolvon, Vivalan and Alival].
Ivanov V; Popov G
Agressologie; 1981 Nov; 22(D):29-30. PubMed ID: 7332038
[No Abstract] [Full Text] [Related]
15. Multicentre study with viloxazine (Vivalan) in depressed patients.
Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
[No Abstract] [Full Text] [Related]
16. [Clinical trials of viloxazine in depressive states].
Fontan M; Goudemand M; Pellerin-Millecamps E
Encephale; 1979; 5(3):243-9. PubMed ID: 385296
[No Abstract] [Full Text] [Related]
17. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of viloxazine hydrochloride.
Vandel B; Vandel S; Allers G; Volmat R
Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
[TBL] [Abstract][Full Text] [Related]
19. Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
Petrie WM; McEvoy JP; Wilson WH; Ban TA; Guy W
Int Pharmacopsychiatry; 1980; 15(3):193-6. PubMed ID: 7016802
[TBL] [Abstract][Full Text] [Related]
20. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
